HSPA5 and colorectal carcinoma: Flow cytometry and western blot results also showed that GRP78-exos treatment weakened the killing effect of 5-FU on CRC cells (Fig. 2F–H), suggesting that GRP78-exos promoted the tolerance of CRC cells to 5-FU.